SEC EDGARSEP 211 min read$AMBA

Young John Alexander sold $128K of AMBA

Young John Alexander (CFO) sold 1,896 shares of AMBARELLA INC (AMBA) at $67.28 ($0.13M total) on 2026-09-18 under a Rule 10b5-1 trading plan.

Original reporting

SEC EDGAR · Young John Alexander

Published Sep 21, 2026, 9:57 PM UTC

Analysis

AlphAI AI DeskAI-generated

Added to AlphAI Sep 21, 2026, 10:13 PM UTC. Informational, not investment advice.

How this was made

AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.

About AlphAI AI Desk Scoring methodology Report an issue

AlphAI market briefInsider activity

Primary signal

$AMBA

Neutral

high confidence

Mentioned

$AMBA

Relevance

3/10

AlphAI data visualization · based on SEC EDGAR

Decision brief

The 30-second read

$AMBANeutralLow

Why it matters

The CFO's sale is modest and pre‑arranged, so market reaction is expected to be minimal.

Market read

A routine insider sale with limited trading relevance.

What to watch

Potential upcoming corporate actions or compensation events not disclosed in the filing.

Relevance 3/10Novelty 4/10Timing: filed Sep 21 2026

Background

Form 4 filings provide the first public disclosure of insider trades, offering transparency into insider holdings.

Company-level read

Ticker impact

AI estimates · verify against primary disclosures

$AMBANeutralHigh confidence

Context

CFO Young John Alexander sold 1,896 shares for $127,563 via a 10b5‑1 plan, reducing his stake to 107,806 shares.

Expected impact

Potential slight downward pressure, but unlikely to move the stock materially.

Evidence & confidence

The transaction size (~$128K) is small relative to market cap and disclosed via a Form 4, making it a routine insider sale.

Market effects

Sector

No broader sector impact; isolated insider transaction.

Regional

None

Global

None

Counterpoint

What could challenge this read

The sale could be interpreted as a lack of confidence, but the 10b5‑1 plan suggests pre‑scheduled execution, not a reaction to company fundamentals.

Key entities

Company
AmbaRELLA Inc.
Medical device manufacturer listed on NASDAQ under ticker AMBA.
Person
Young John Alexander
Chief Financial Officer of AmbaRELLA Inc.

Read at source ← All news

SEP 23

$AMBAHighAI 8/10

Ambarella speculated to have a rival suitor - Betaville

Ambarella (AMBA) may have a second potential buyer, following reports of NXP Semiconductors (NXPI) exploring an acquisition. Traders suggest a bid of 75% cash and 25% shares, valued between $95 and $105 per share, citing a Betaville alert. The identity of the new suitor is unknown.

tradingview.com1 min

SEP 20

$AMBAHighAI 9/10

ZEDEDA Deal Targets $30B Edge AI Market

Ambarella and ZEDEDA announced a partnership on September 15, 2026, integrating ZEDEDA's EVE-OS with Ambarella's N1 edge AI chips. The deal targets the $30B edge AI market, with developer kits expected in Q4 2026. Ambarella reported Q2 2026 revenue of $108.1M, up 13.2% YoY, while ZEDEDA has raised over $129M in funding.

shattered.io3 min

SEP 15

$AMBAMed

Existing cameras and robots can add AI without a redesign

Ambarella (AMBA) launched X7, a standalone AI accelerator chip, on September 15, 2026. X7 adds AI capabilities to existing systems without redesign, operating within 2-5 watts. It supports various AI models and is available for sampling. AMBA stock gained 1.98% post-announcement, trading at $65.25.

stocktitan.net3 min

SEP 13

$AMBAMed

Ambarella CEO Sees Edge AI Growth Across Security, Autos and Wearables

Ambarella CEO Feng-Ming Wang highlighted growth opportunities in edge AI across security, automotive, and wearables. He noted the company's competitive advantages in power efficiency and partnerships with Aurora, Continental, and Bosch. Automotive accounts for 30% of revenue, with potential for large design wins. Wang expects 10-15% revenue growth for fiscal 2027, citing broader edge AI adoption and stable gross margins.

yahoo.com3 min

SEP 9

$AMBAHighAI 8/10

Ambarella (AMBA) Q2 2027 Earnings Call Transcript

Ambarella (AMBA) reported Q2 2027 revenue of $108.1M, up 13.2% YoY, slightly exceeding guidance. Non-GAAP gross margin was 59.3%, below midpoint due to product mix changes. Automotive revenue hit record levels, and IoT segment grew sequentially. The company forecasted a serviceable addressable market growing to $22.9B by 2032. Q3 revenue guidance is $115M to $124M, with non-GAAP gross margin expected between 59.0% and 60.0%. Management noted risks from memory price surges and supply chain costs.

aol.com3 min